NCT02310425View on ClinicalTrials.gov

A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

January 31, 2014

Conditions
Infant, Premature, Diseases
Interventions
DRUG

S. boulardii

50 mg/kg twice daily

DRUG

Placebo

he control group (group C) did not receive S. boulardii (nor other probiotics)

All Listed Sponsors
lead

Lingfen Xu, MD

OTHER

NCT02310425 - A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants | Biotech Hunter | Biotech Hunter